144 related articles for article (PubMed ID: 29400464)
1. Conformational Flexibility Is a Determinant of Permeability for Cyclosporin.
Wang CK; Swedberg JE; Harvey PJ; Kaas Q; Craik DJ
J Phys Chem B; 2018 Mar; 122(8):2261-2276. PubMed ID: 29400464
[TBL] [Abstract][Full Text] [Related]
2. Kinetic Models of Cyclosporin A in Polar and Apolar Environments Reveal Multiple Congruent Conformational States.
Witek J; Keller BG; Blatter M; Meissner A; Wagner T; Riniker S
J Chem Inf Model; 2016 Aug; 56(8):1547-62. PubMed ID: 27387150
[TBL] [Abstract][Full Text] [Related]
3. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.
Matsui K; Kido Y; Watari R; Kashima Y; Yoshida Y; Shuto S
Chemistry; 2017 Mar; 23(13):3034-3041. PubMed ID: 27878880
[TBL] [Abstract][Full Text] [Related]
4. Solution structures of cyclosporin a and its complex with dysprosium(III) in SDS micelles: NMR and molecular dynamics studies.
Bernardi F; D'Amelio N; Gaggelli E; Molteni E; Valensin G
J Phys Chem B; 2008 Jan; 112(3):828-35. PubMed ID: 18095667
[TBL] [Abstract][Full Text] [Related]
5. Large-Scale Membrane Permeability Prediction of Cyclic Peptides Crossing a Lipid Bilayer Based on Enhanced Sampling Molecular Dynamics Simulations.
Sugita M; Sugiyama S; Fujie T; Yoshikawa Y; Yanagisawa K; Ohue M; Akiyama Y
J Chem Inf Model; 2021 Jul; 61(7):3681-3695. PubMed ID: 34236179
[TBL] [Abstract][Full Text] [Related]
6. Interconversion Rates between Conformational States as Rationale for the Membrane Permeability of Cyclosporines.
Witek J; Mühlbauer M; Keller BG; Blatter M; Meissner A; Wagner T; Riniker S
Chemphyschem; 2017 Dec; 18(23):3309-3314. PubMed ID: 28921848
[TBL] [Abstract][Full Text] [Related]
7. Conformation of cyclosporin A in polar solvents.
Ko SY; Dalvit C
Int J Pept Protein Res; 1992 Nov; 40(5):380-2. PubMed ID: 1483832
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A: Conformational Complexity and Chameleonicity.
Ono S; Naylor MR; Townsend CE; Okumura C; Okada O; Lee HW; Lokey RS
J Chem Inf Model; 2021 Nov; 61(11):5601-5613. PubMed ID: 34672629
[TBL] [Abstract][Full Text] [Related]
9. Conformation and Permeability: Cyclic Hexapeptide Diastereomers.
Ono S; Naylor MR; Townsend CE; Okumura C; Okada O; Lokey RS
J Chem Inf Model; 2019 Jun; 59(6):2952-2963. PubMed ID: 31042375
[TBL] [Abstract][Full Text] [Related]
10. Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability.
Wang CK; Northfield SE; Swedberg JE; Colless B; Chaousis S; Price DA; Liras S; Craik DJ
Eur J Med Chem; 2015 Jun; 97():202-13. PubMed ID: 25974856
[TBL] [Abstract][Full Text] [Related]
11. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides.
Rezai T; Bock JE; Zhou MV; Kalyanaraman C; Lokey RS; Jacobson MP
J Am Chem Soc; 2006 Nov; 128(43):14073-80. PubMed ID: 17061890
[TBL] [Abstract][Full Text] [Related]
12. Lipid bilayer membrane permeability mechanism of the K-Ras(G12D)-inhibitory bicyclic peptide KS-58 elucidated by molecular dynamics simulations.
Sakamoto K; Hirokawa T
Bioorg Med Chem Lett; 2024 Mar; 100():129649. PubMed ID: 38341162
[TBL] [Abstract][Full Text] [Related]
13. Polar/apolar interfaces modulate the conformational behavior of cyclic peptides with impact on their passive membrane permeability.
Linker SM; Schellhaas C; Ries B; Roth HJ; Fouché M; Rodde S; Riniker S
RSC Adv; 2022 Feb; 12(10):5782-5796. PubMed ID: 35424539
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclosporin variants B-E based on their structural properties and activity in mitochondrial membranes.
Efimov SV; Dubinin MV; Kobchikova PP; Zgadzay YO; Khodov IA; Belosludtsev KN; Klochkov VV
Biochem Biophys Res Commun; 2020 Jun; 526(4):1054-1060. PubMed ID: 32307084
[TBL] [Abstract][Full Text] [Related]
15. Cyclic Peptide Design Guided by Residual Dipolar Couplings, J-Couplings, and Intramolecular Hydrogen Bond Analysis.
Farley KA; Che Y; Navarro-Vázquez A; Limberakis C; Anderson D; Yan J; Shapiro M; Shanmugasundaram V; Gil RR
J Org Chem; 2019 Apr; 84(8):4803-4813. PubMed ID: 30605335
[TBL] [Abstract][Full Text] [Related]
16. Cis-trans isomerization in cyclosporin C dissolved in acetonitrile.
Minnullina GA; Efimov SV; Klochkov VV
Biochem Biophys Res Commun; 2023 Nov; 683():149102. PubMed ID: 37857163
[TBL] [Abstract][Full Text] [Related]
17. Modeling conformational changes in cyclosporin A.
O'Donohue MF; Burgess AW; Walkinshaw MD; Treutlein HR
Protein Sci; 1995 Oct; 4(10):2191-202. PubMed ID: 8535256
[TBL] [Abstract][Full Text] [Related]
18. Development of the force field for cyclosporine A.
Yamane T; Ekimoto T; Ikeguchi M
Biophys Physicobiol; 2022; 19():e190045. PubMed ID: 36567735
[TBL] [Abstract][Full Text] [Related]
19. Binding of Different Cyclosporin Variants to Micelles Evidenced by NMR and MD Simulations.
Kobchikova PP; Efimov SV; Klochkov VV
Membranes (Basel); 2023 Feb; 13(2):. PubMed ID: 36837699
[TBL] [Abstract][Full Text] [Related]
20. Cell-permeable chameleonic peptides: Exploiting conformational dynamics in de novo cyclic peptide design.
Ramelot TA; Palmer J; Montelione GT; Bhardwaj G
Curr Opin Struct Biol; 2023 Jun; 80():102603. PubMed ID: 37178478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
